Seattle Genetics(美国)

Seattle Genetics

美国SeattleGenetics www.seagen.comSeattleGenetics公司是美国的一家研发治疗肿瘤和免疫类疾病的单克隆抗体药物的生物技术公司。该公司在抗体偶联技术方面比较有优势，正在研发多种偶联抗癌剂的抗体药物。AtSeattleGenetics,wearecommittedtodevelopinginnovativeantibody-basedtherapiesthati mproveclinicaloutcomesforpatientswithcancerandautoimmunediseases.Wearededicatedtoaddressingunmetmedicalneed,andstrivetoachievethatgoalthroughanunwaveringcommitmenttoexcellenceinclinicaldevelopment.FocusingonClinicalDevelopmentSeattleGeneticsisaclinicalstagebiotechnologycompanyadvancingabroadproductpipelineofantibody-basedtherapies.Ourleadprogram,brentuximabvedotin(SGN-35),isinapivotaltrialunderaSpecialProtocolAssessmentwiththeFDAforpatientswithrelapsedorrefractoryHodgkinlymphoma.BrentuximabvedotinisempoweredbySeattleGenetics'proprietaryantibody-drugconjugate(ADC)technology.Inaddition,weareconductingclinicaltrialswithfourotherproduct